Skip to main content

Table 2 Comparison of clinical indexes of diabetic foot ulcer patients infected with sensitive bacteria and multidrug resistant bacteria

From: Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection

Index

Infected with Sensitive Bacteria(n = 62)

Infected with Multidrug resistant bacteria(n = 84)

P Value

 Sex (M/F)

41/21

52/32

0.600

 Age

50.24 ± 8.71

49.39 ± 12.29

0.643

 Diabetes duration (years)

10.51 ± 6.32

9.75 ± 5.94

0.458

 BMI(kg/m2)

24.87 ± 3.18

30.11 ± 3.61

0.000*

 HbA1c(%)

7.91 ± 0.85

9.82 ± 0.93

0.000*

 FPG(mmol/l)

9.35 ± 1.74

11.51 ± 1.90

0.000*

 TG (mmol/l)

2.05 ± 1.58

2.69 ± 0.92

0.003*

 TC (mmol/l)

4.67 ± 1.20

4.45 ± 0.88

0.203

 HDL-c (mmol/l)

1.29 ± 0.45

1.31 ± 0.38

0.772

 LDL-c (mmol/l)

2.79 ± 0.80

2.87 ± 0.78

0.546

 Ulcer course(Month)

1.51 ± 0.92

2.20 ± 1.26

0.000*

 Ulcer size(cm2)

15.21 ± 10.41

26.12 ± 14.79

0.000*

Wagners Grade

 I

2(3.23%)

4(4.76%)

0.644

 II

25(40.32)

31(36.90%)

0.675

 II

12(19.35%)

16(19.05%)

0.963

 IV

23(37.10%)

33(39.29%)

0.788

 Amorbidities

   

 Hypertension

24(38.71%)

38(45.24%)

0.430

 Retinopathy

32(51.61%)

47(55.95%)

0.603

 Peripheral neuropathy

25(40.32%)

57(67.86%)

0.001*

 Kidney disease

32(51.61%)

47(55.95%)

0.603

 Peripheral vascular lesions

28(45.16%)

61(72.62%)

0.001*

 Osteomyelitis

5(8.06%)

24(28.57%)

0.002*

 White blood cell count (*103)

9.21 ± 1.87

6.51 ± 1.77

0.000*

 Neutrophil percentage (%)

50.13 ± 17.61

38.42 ± 15.25

0.000*

 Use of antimicrobial drugs within the last 3 months

36(58.06%)

64(78.05%)

0.020*

  1. Abbreviations: BMI Body mass index, HbA1c Hemoglobin A1c, FPG Fasting plasma glucose, TG Triglyceride, TC Total cholesterol, HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol
  2. Data are expressed as mean ± SD or percentage. *P < 0.05 compared with infected with sensitive bacteria group